EP3842035A1 — Composition for the preparation of perindopril arginine granules, a method for their preparation and pharmaceutical composition comprising the granules
Assigned to KRKA dd · Expires 2021-06-30 · 5y expired
What this patent protects
The present invention relates to granules comprising perindopril arginine, as well as to a process for the preparation of granules comprising perindopril arginine. Furthermore, the present invention pertains to a pharmaceutical composition comprising granules comprising perindopr…
USPTO Abstract
The present invention relates to granules comprising perindopril arginine, as well as to a process for the preparation of granules comprising perindopril arginine. Furthermore, the present invention pertains to a pharmaceutical composition comprising granules comprising perindopril arginine.
Drugs covered by this patent
- Caduet (Amlodipine Besylate) · Pfizer Inc.
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.